Progression of esophageal dysmotility in systemic sclerosis

Journal of Rheumatology

Volumn 39, Issue 5, 2012, Pages 986-991

  Vischio, John ^b   Saeed, Fahd ^a,c   Karimeddini, Mozafareddin ^d   Mubashir, Asia ^d   Feinn, Richard ^b   Caldito, Gloria ^a,c   Striegel, Kim ^b   Rothfield, Naomi ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

Esophageal dysmotility; Esophageal transit scintigraphy; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY; GASTROINTESTINAL AGENT; SCL 70 ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; DISEASE COURSE; ESOPHAGUS DYSMOTILITY; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MOTILITY; ESOPHAGUS SCINTISCANNING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84860712629     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110923     Document Type: Article

References (27)

1. Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003;21:S15-8.
2. Sjögren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994;37:1265-82. (Pubitemid 24320743)
3. Poirier T, Rankin M. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972;58:30-44.
4. Turner R, Lipshutz W, Miller W, Rittenberg G, Schumacher HR, Cohen S. Oesophageal dysfunction in collagen disease. Am J Med Sci 1973;265:191-9.
5. Kaye SA, Siraj QH, Agnew J, Hilson A, Black CM. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphy grading method. J Rheumatol 1996;23:297-301. (Pubitemid 26078386)
6. Forbes A, Marie I. Gastrointestinal complications: the most frequent internal complication of systemic sclerosis. Rheumatology 2009;48:iii36-9.
7. Wipff J, Allanore Y, Soussi F, Terris B, Abitbol V, Raymond J, et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005;52:2882-8. (Pubitemid 41369119)
8. Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, et al. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987;82:46-52. (Pubitemid 17087032)
9. Taillefer R, Jadliwalla M, Pellerin E, Lafontaine E, Duranceau A. Radionuclide esophageal transit study in detection of esophageal motor dysfunction: Comparison with motility studies (manometry). J Nucl Med 1990;31:1921-6.
10. Mughal MM, Marples M, Bancewicz J. Scintigraphic assessment of esophageal motility: What does it show and how reliable is it? Gut 1986;27:946-53. (Pubitemid 16044268)
11. Tatsch K, Voderholzer WA, Weiss MJ, Schrottle W, Hahn K. Re-appraisal of quantitative esophageal scintigraphy by optimizing results with ROC analyses. J Nucl Med 1996;37:1799-805. (Pubitemid 26378365)
12. Klein HA. Receiver operating characteristic surfaces for esophageal transit scintigraphy in systemic sclerosis [abstract]. Eur J Nucl Med 1991;16 Suppl:S31.
13. Edenbrandt L, Theander E, Hogstrom M, Scheja A, Akesson A, Palmer J. Esophageal scintigraphy in normal subjects and patients with systemic sclerosis. J Nucl Med 1995;36:1533-7.
14. Geatti O, Shapiro B, Fig LM, Fossaluzza V, Franzon R, De Vita S, et al. Radiolabelled semisolid test meal clearance in the evaluation of esophageal involvement in scleroderma and Sjogren's syndrome. Am J Physiol Imaging 1991;6:65-73.
15. Cozzi F, Zucchetta P, Durigon N, Marzola MC, Bullo A, Favaro M, et al. Esophageal dysmotility in scleroderma patients with different forms of disease and ANA patterns: A scintigraphic study in 100 cases. Reumatismo 2003;55:86-92. (Pubitemid 36735532)
16. Baron M, Arzoumanian A. Radionuclide esophageal transit studies in progressive systemic sclerosis: An analysis of longitudinal data. J Rheumatol 1991;18:1837-40.
17. Dantas RO, Meneghelli UG, Oliveira RB, Villanova MG. Esophageal dysfunction does not always worsen in systemic sclerosis. Clin Gastroenterol 1993;17:281-5. (Pubitemid 23360378)
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
19. Clements PJ, Lachenbruch PA, Ng SW, Simmons M, Sterz M, Furst DE. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990;33:1256-63. (Pubitemid 20273315)
20. Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: Gastroesophageal reflux, the common problem. Semin Arthritis Rheum 2006;36:173-81. (Pubitemid 44767593)
21. Lapadula G, Muolo P, Semeraro F, Covelli M, Brindicci D, Cuccorese G, et al. Esophageal motility disorders in the rheumatic diseases: A review of 150 patients. Clin Exp Rheumatol 1994;12:515-21. (Pubitemid 24323895)
22. Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001;45:346-54. (Pubitemid 32738740)
23. Airò P, Della Casa D, Danieli E, Missale G, Cattaneo R, Cestari R. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 2005;24:370-6. (Pubitemid 41102435)
24. Nakajima K, Hasegawa M, Inaki A, Wakabayashi H, Hosoya T, Takehara K, et al. Esophageal transit study using a sliding sum image: Application to patients with probable and definite systemic sclerosis. Ann Nucl Med 2011;25:325-31.
25. Nakajima K, Kawano M, Kinuya K, Sato S, Takehara K, Tonami N. The diagnostic value of oesophageal transit scintigraphy for evaluating the severity of oesophageal complications in systemic sclerosis. Nucl Med Commun 2004;25:375-81. (Pubitemid 38553358)
26. Davidson A, Russell C, Littlejohn GO. Assessment of esophageal abnormalities in progressive systemic sclerosis using radionuclide transit. J Rheumatol 1985;12:472-7. (Pubitemid 15004942)
27. Pakozdi A, Wilson H, Black CM, Denton CP. Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? Clin Exp Rheumatol 2009;3 Suppl 54:5-8.